Video Experimental Relacionado
Updated: Feb 27, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Índice de acoplamiento auriculoventricular izquierdo predice mal pronóstico en infarto agudo de miocardio: un estudio
Chuyun Chen1, Haolei Huang1, Jia Jia1,2
1Department of Cardiology, Peking University First Hospital, Beijing 100034, China.
Abstract:
(1) Background: The left atrioventricular coupling index (LACI) is a novel parameter for evaluating cardiac function. This study focused on its association with major adverse cardiovascular events (MACEs) in acute myocardial infarction (AMI) patients. (2) Methods: A retrospective cohort of AMI patients from Peking University First Hospital was enrolled. All underwent transthoracic echocardiography on admission for LACI measurement. The primary endpoint was MACE (a composite of nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death). (3) Results: Among 843 AMI patients (62.07 ± 12.24 years, 77.94% male), the median LACI was 0.24 (IQR 0.18-0.33). During a median follow-up of 4.31 years, 151 patients (17.91%) developed MACE. The optimal LACI cutoff for risk stratification was 0.257. After multivariable adjustment, each standard deviation increase in LACI was associated with significantly elevated risks of MACE (HR 1.17, 95% CI 1.02-1.34), all-cause death (HR 1.19, 95% CI 1.05-1.35), cardiovascular death (HR 1.33, 95% CI 1.10-1.61), and stroke (HR 1.23, 95% CI 1.05-1.43). (4) Conclusions: LACI is an independent predictor of poor prognosis in AMI patients and may serve as a valuable tool for risk stratification in secondary prevention.
Más Videos Relacionados
Videos de Conceptos Relacionados
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Coronary Artery Disease II: Pathophysiology

